Catalyst Wire Dossier Catalyst Wire Dossier

Alprazolam 0.25 mg tablets

alprazolam · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alprazolam 0.25 mg tablets, covering 2017-06-14 to 2017-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Trial of Alprazolam 0.25 mg Tablets [Phase 1]

See pricing